As shown in Fig. 1B–F, tamoxifen inhibited cell growth in a dose- and time-dependent manner, not only in the hormone receptor-positive cell line, but also in the hormone receptor-negative cells lines, which suggests that tamoxifen repressed growth in pancreatic cancer cells independently of the hormone receptor status. Here, NR4A1 is linked to familial pancreatic carcinoma.